Changes in protein expression levels can also impact drug efficacy. Overexpression or underexpression of the target protein can alter the drug's ability to bind effectively. For example, overexpression of HER2 in breast cancer can lead to increased resistance to HER2-targeted therapies, requiring alternative or combination treatments.
